Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In the SELECT trial, people who did not have diabetes but had body mass indexes (BMIs) that put them in the overweight or obese category experienced a reduced incidence of heart attack, stroke, and death after taking the medication
Whats next for patients using compounded GLP-1s
The PlexusDx Precision Peptide Genetic Test identifies whether you carry variants in GIPR and FTO, or MC4R genes that affect how your body responds to weight loss hormones
Patients should inform their pharmacist or physician about all medications they are currently taking, including: Discussing current medications, such as metformin , liraglutide , or any herbal products , with a healthcare provider is essential to avoid potential interactions
Additionally, investigation of GIP in combination with other appetite-regulating hormones (GLP-1, PYY, CCK) promises further optimization of metabolic weight loss strategies
